Aurobindo receives FDA approval for loperamide hydrochloride capsules USP, 2mg
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application loperamide hydrochloride capsules USP, 2mg.